Pfizer Corporation

Norden Laboratories, Inc.

Joseph C Frantz

David S Roberts

Leroy A Swearingin

Albert L Brown

Richard H Peetz

Richard J Kemmy

Paul Joseph Dominowski

Richard Lee Krebs

Shelly Lynn Shields

Robert Greg Sorensen

This invention relates to vaccines and methods for protecting dogs against disease caused by. This invention also relates to combination vaccines and methods for protecting dogs against disease or disorder caused by canine pathogens, for example, infectious tracheobronchitis caused by, canine distemper caused by canine distemper (CD) virus, infectious canine hepatitis (ICH) caused by canine adenovirus type 1 (CAV-1), respiratory disease caused by canine adenovirus type 2 (CAV-2), canine parainfluenza caused by canine parainfluenza (CPI) virus, enteritis caused by canine coronavirus (CCV) and canine parvovirus (CPV), and leptospirosis caused byor. The vaccines of the present invention include ap68 antigen.

Canine combination vaccines

Pasteurella multocida toxoid vaccines

This invention provides vaccine compositions, methods of producing same and methods for protecting porcine animals against disease associated with infection by toxigenic Pasteurella multocida. The vaccines of this invention contain effective amounts of a free, soluble P. multocida toxoid and/or a P. multocida bacterin with a cell-bound toxoid.

A vaccine for protecting canines against infection by Bordetella bronchiseptica is prepared by inactivating whole cells with glutaraldehyde.

Bordetella bronchiseptica vaccine

Bordetella Bronchiseptica vaccine

Growing community of inventors

Lincoln, NE, United States of America

Joseph C Frantz